Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy is available on the NHS in the UK, but access is tightly controlled and criteria are strict — most adults asking this question will not currently qualify. The honest answer is that free NHS access exists through specialist weight management services, though waiting lists are long and eligibility thresholds are high. Wegovy is a prescription-only medicine requiring clinical assessment; a prescriber decides whether it is suitable for you specifically, not a checklist.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is a question our prescribers hear most weeks, and the short answer is: yes, but the conditions attached are significant. NICE recommended semaglutide for weight management in 2023 under guidance TA875, but only within specialist weight management services that provide full multidisciplinary care, not as a standard GP prescription. For most patients, that means a formal referral to a Tier 3 or Tier 4 service, which in many parts of England involves a wait measured in months rather than weeks.
To be considered under the NHS pathway, adults generally need a BMI of 35 or above and at least one weight-related condition such as high blood pressure, type 2 diabetes, or obstructive sleep apnoea. NICE's thresholds are set 2.5 kg/m² lower for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds. A BMI of 30 to 34.9 may be considered if referral criteria are met through the specialist service itself. NICE also specifies a maximum of two years of treatment on this NHS route, and recommends reviewing whether to continue if less than 5% weight loss has occurred after six months on the maintenance dose.
Scotland, Wales and Northern Ireland operate their own criteria, which differ from the above, so the picture varies depending on where you live. You can read more about whether Wegovy might be the right fit for you on our Wegovy suitability page.
Even people who meet the BMI and comorbidity thresholds often find that local services are oversubscribed. NHS England runs weight management injection programmes that include Wegovy, but commissioning varies by Integrated Care Board. A person in one area might be seen within three months; in another, the same person joins a list with no clear timeline. The two-year ceiling under TA875 also means the NHS pathway is designed as a time-limited intervention, with lifestyle support built in rather than ongoing prescription alone.
Demand has grown sharply since clinical trials showed semaglutide produced around 15% average weight loss over 68 weeks, results that, understandably, prompted a wave of interest. Supply has not always kept pace. That gap is partly why many people end up exploring private routes. It is also worth being clear that Ozempic, the same molecule prescribed for type 2 diabetes, is not a route to free weight-loss treatment, it is licensed specifically for diabetes management, not weight loss, and should never be sourced for that purpose.
For a broader overview of how semaglutide works and its UK licensed uses, our semaglutide information page covers the clinical background in full.
If you do not meet the current NHS thresholds, or you are not willing to wait, a private prescription from a regulated online pharmacy is the legal alternative. Wegovy remains a prescription-only medicine on the private route too, that does not change. What changes is the process: rather than a GP referral and a specialist waiting list, you complete a consultation that a GPhC-registered Independent Prescriber reviews the same day. Identity and weight are verified before any prescription is issued.
Private treatment does carry a cost. For context on what private Wegovy typically costs and what a legitimate price should include, our Wegovy private prescription page explains the pricing landscape honestly, including why prescription and aftercare should always be part of the figure you are quoted. nume is deliberately not positioned as the cheapest option, one transparent price covers the consultation, prescription, and free next-working-day delivery, with prescriber-led aftercare seven days a week.
If you are already on Wegovy privately and wondering about practical questions like storage, our page on whether you can freeze Wegovy covers what the guidance says. And if you have questions about the broader Wegovy treatment overview, that is a good place to start before a consultation.
There is no legal shortcut. Semaglutide sold without a prescription, through social media, or at prices far below the market rate is a serious safety risk. The MHRA has warned repeatedly about counterfeit weight-loss pens, some of which have contained insulin rather than the labelled medicine. If a seller is offering Wegovy cheaply with no clinical assessment involved, that is a red flag, not a bargain. You can report suspect sellers via the MHRA's Yellow Card scheme, which also accepts reports of genuine side effects.
There are no discount codes, voucher schemes or subsidised access programmes for Wegovy outside the NHS. Anyone claiming otherwise (whether a website or a social media account) is either misinformed or, more concerning, operating outside the law. The dedicated page on whether Wegovy is ever free goes into more detail on what legitimate access looks like and what to watch out for. If you think you may qualify for NHS access, speak to your GP about a referral. If you would like to explore private treatment, you can check your eligibility with our prescribers at no cost.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.